BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8475862)

  • 1. Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy.
    Herlitz J; Hartford M; Aune S; Karlsson T
    Am J Cardiol; 1993 May; 71(12):1021-4. PubMed ID: 8475862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
    Gemmill JD; Hogg KJ; Douglas JT; Dunn FG; Lowe GD; Rae AP; Hillis WS
    Eur Heart J; 1993 Jun; 14(6):819-25. PubMed ID: 8325311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the possibility of accelerating thrombolytic therapy in the acute phase of myocardial infarction: efficacy of and tolerance to the infusion of 1.5 million units of streptokinase in 30 minutes].
    Mazzotta G; Cavazzana G; Camerini A; Lupi G; Vecchio C
    G Ital Cardiol; 1989 Jan; 19(1):53-8. PubMed ID: 2744315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
    Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
    Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of arterial pressure during administration of intravenous streptokinase, in patients with acute myocardial infarct].
    Torres S; Albuquerque A; Gomes L; Pimenta A
    Rev Port Cardiol; 1989 Apr; 8(4):269-73. PubMed ID: 2631844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptokinase-induced transient aggravation of myocardial injury.
    Arstall MA; Stewart S; Haste MA; Horowitz JD
    Int J Cardiol; 1995 Jun; 50(2):107-16. PubMed ID: 7591321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arterial blood pressure behavior during the administration of intravenous streptokinase, in patients with acute myocardial infarction].
    Torres S; Albuquerque A; Gomes L; Pimenta A
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-147-52. PubMed ID: 11515289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolysis and beta-block in acute myocardial infarct. Their effects on left ventricular function].
    Olvera R; Moguel R; Meaney E; Dávila A; González V; Samaniego V
    Arch Inst Cardiol Mex; 1993; 63(4):339-44. PubMed ID: 8215706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment with intravenous metoprolol for suspected acute myocardial infarction: a phase IV United States trial. Phase IV Metoprolol in Myocardial Infarction Study Group.
    Antman EM; Dupont WD; Bonalsky J; Califf RM; Corwin S; Fink L; Hansen DE; Kawanishi DT; Kronenberg MW; McKay CR
    Int J Cardiol; 1989 May; 23(2):185-97. PubMed ID: 2656541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.
    Lew AS; Laramee P; Cercek B; Shah PK; Ganz W
    Circulation; 1985 Dec; 72(6):1321-6. PubMed ID: 4064276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute myocardial infarction survival rate and complications after streptokinase therapy in Hospital Universiti Sains Malaysia, Kelantan--a comparative study.
    Hishamuddin HM; Azmi NN; Jackson N
    Singapore Med J; 1993 Aug; 34(4):316-8. PubMed ID: 8266202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrupt complement activation and transient neutropenia in patients with acute myocardial infarction treated with streptokinase.
    Frangi D; Gardinali M; Conciato L; Cafaro C; Pozzoni L; Agostoni A
    Circulation; 1994 Jan; 89(1):76-80. PubMed ID: 7741820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.